A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China.
Hu, Dawei
A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China. [electronic resource] - Rheumatology international Jan 2009 - 297-303 p. digital
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
0172-8172
10.1007/s00296-008-0681-x doi
Administration, Oral
Adult
Aged
Antirheumatic Agents--administration & dosage
Arthritis, Rheumatoid--drug therapy
China
Double-Blind Method
Etanercept
Female
Humans
Immunoglobulin G--administration & dosage
Injections, Subcutaneous
Male
Methotrexate--administration & dosage
Middle Aged
Receptors, Tumor Necrosis Factor--administration & dosage
Recombinant Fusion Proteins--administration & dosage
Treatment Outcome
Young Adult
A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China. [electronic resource] - Rheumatology international Jan 2009 - 297-303 p. digital
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
0172-8172
10.1007/s00296-008-0681-x doi
Administration, Oral
Adult
Aged
Antirheumatic Agents--administration & dosage
Arthritis, Rheumatoid--drug therapy
China
Double-Blind Method
Etanercept
Female
Humans
Immunoglobulin G--administration & dosage
Injections, Subcutaneous
Male
Methotrexate--administration & dosage
Middle Aged
Receptors, Tumor Necrosis Factor--administration & dosage
Recombinant Fusion Proteins--administration & dosage
Treatment Outcome
Young Adult